COVID-19 VACCINATIONS: If, in addition to indemnity for your main employment, you would like cover for delivering COVID-19 Vaccinations please apply for our standalone extension Apply Today

Home  »   Latest News   »   PDA members in the Boots Pension Scheme to complain about the removal of an unreduced pension option

PDA members in the Boots Pension Scheme to complain about the removal of an unreduced pension option

PDA members have sought support from their union following recent communications about the removal of the option to take a full pension from age 60.

Tue 19th December 2023 The PDA

PDA members have sought support from their union following the recent communications from the trustees of the closed final salary pension scheme run by Boots, known as the “Boots Pension Scheme”. The trustees’ decision to secure a buy-in of the benefits through an arrangement with Legal and General included the removal of the option to take a full pension from age 60, PDA members who have benefits in the Scheme and who have concerns about the change have the right to use the disputes procedure at Boots to complain about the removal of the option to retire at 60 without a reduced pension.

Paul Moloney, PDA Union national officer explains why members may want to do this.

“We have considered, with our advisors, the claim by the trustees of the scheme that the option to take an unreduced pension from 60 was discretionary and not a right and believe there is insufficient evidence to fully support this claim. We are therefore questioning whether this option should have been secured as part of the buy in and not ended with immediate effect.

Instead, we believe benefit statements issued to members, at the very least are contradictory, and clearly state that a full pension will be payable from a member’s 60th birthday, with no reference to this benefit being discretionary and therefore subject to a regular review by the trustees. Instead, the benefit statements give the impression that an unreduced pension from 60 is a right with no indication that retirement plans should not be based on the benefit statements.

Although we recognise the advantages a buy-in can bring to the overall security of benefits it is important that it is done correctly. We believe there is sufficient doubt over the claim that the unreduced pension was discretionary and can be ended with the buy in.  Members can challenge this through the scheme’s disputes procedure initially and if unresolved through the Pension Ombudsman who is there to resolve matters such as this.”

The PDA held an online meeting of over 100 members affected and will now be sending template complaint letters setting out concerns regarding the discretionary nature of the benefit and the way it has been communicated to scheme members over the years.  The templates are for PDA members to complete and submit to the scheme administrators as the first stage of a formal complaint.

Learn more

Not yet a PDA member?

If you have not yet joined the PDA, we encourage you to join today and ask your colleagues to do the same.

Membership is FREE to pharmacy students, trainee pharmacists, and for the first three months of being newly qualified.

JOIN THE PDA TODAY

Read about our key member benefits here.

 

 

 

 

 

The Pharmacists' Defence Association is a company limited by guarantee. Registered in England; Company No 4746656.

The Pharmacists' Defence Association is an appointed representative in respect of insurance mediation activities only of
The Pharmacy Insurance Agency Limited which is registered in England and Wales under company number 2591975
and is authorised and regulated by the Financial Conduct Authority (Register No 307063)

The PDA Union is recognised by the Certification Officer as an independent trade union.

Cookie Use

This website uses cookies to help us provide the best user experience. If you continue browsing you are giving your consent to our use of cookies.

General Guidance Resources Surveys PDA Campaigns Regulations Locums Indemnity Arrangements Pre-Regs & Students FAQs Coronavirus (COVID-19)